Invest India, in partnership with the Department of Pharmaceuticals and the Federation of Indian Chambers of Commerce & Industry (FICCI), organised the 7th edition of the India Pharmaceuticals and Medical Devices Summit in New Delhi.  
 
The three-day event witnessed a conglomeration of policymakers, industry captains from pharmaceuticals and medical devices, micro, small and medium enterprises (MSMEs), innovators, and academia. The deliberations envisaged redefining the role of pharmaceuticals and medical devices in realising the vision of universal healthcare in India. 
 
During the Summit, Invest India organised two dedicated Investor Forums with the approved Production linked Incentive (PLI) applicants for Pharmaceuticals and Medical Devices to map the progress achieved by investors and outline the way forward for the growth of the sectors. S. Aparna chaired the closed-door discussion with the PLI applicants, Secretary, Department of Pharmaceuticals, in the presence of senior stakeholders from the Department of Pharmaceuticals, Project Management Agencies of PLI (Industrial Finance Corporation of India (IFCI) and Small Industries Development Bank of India (SIDBI)), and Central Drugs Standard Control Organisation (CDSCO). The respective sessions for pharmaceuticals and medical devices concluded with an interactive discussion. They laid down a roadmap to boost the domestic production of pharma products and medical devices in realising the vision of “Aatmanirbhar Bharat.” 
 
Invest India’s thought leadership report on “Enabling Growth and Innovation in the Indian Medical Devices Sector”, written in collaboration with The Asia Pacific Medical Technology Association (APACMed) and KPMG, was also released by Mansukh Mandaviya, Minister of Health and Family Welfare, Bhagwanth Khuba, Ministry of State (MoS) of Chemicals and Fertilisers, and S. Aparna, Secretary, Department of Pharmaceuticals during the Summit.